Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis

Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis

Abstract Introduction Tralokinumab and dupilumab are biological agents licensed for the treatment of moderate-to-severe atopic dermatitis (AD) in adult patients who are candidates for systemic treatment. However, no head-to-head studies of their efficacy have been conducted. This study indirectly co...

Full description

Saved in:
Bibliographic Details
Main Authors: Tiago Torres, Anne Sohrt Petersen, Ulla Ivens, Albert Bosch Vilaro, John Stinson, José Manuel Carrascosa
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-04-01
Series:Dermatology and Therapy
Subjects:
Atopic dermatitis
Dupilumab
Matching-adjusted indirect comparison
Topical corticosteroids
Tralokinumab
Online Access:https://doi.org/10.1007/s13555-024-01143-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s13555-024-01143-x

Similar Items